Relmada Therapeutics, Inc. (RLMD) SEC Filings https://www.relmada.com/for-investors/sec-filings/rss Relmada Therapeutics, Inc. (RLMD) - SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/relmada/files/theme/images/logo-sm.png Relmada Therapeutics, Inc. Logo /for-investors Equisolve Investor Relations Suite <![CDATA[8-K - Current report]]> https://www.relmada.com/for-investors/sec-filings/content/0001213900-26-062184/0001213900-26-062184.pdf Thu, 28 May 26 17:00:19 -0400 https://www.relmada.com/for-investors/sec-filings/content/0001213900-26-062184/0001213900-26-062184.pdf <![CDATA[S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers]]> https://www.relmada.com/for-investors/sec-filings/content/0001213900-26-055901/0001213900-26-055901.pdf Wed, 13 May 26 16:53:36 -0400 https://www.relmada.com/for-investors/sec-filings/content/0001213900-26-055901/0001213900-26-055901.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.relmada.com/for-investors/sec-filings/content/0000919574-26-002929/0000919574-26-002929.pdf Wed, 13 May 26 09:15:55 -0400 https://www.relmada.com/for-investors/sec-filings/content/0000919574-26-002929/0000919574-26-002929.pdf <![CDATA[8-K - Current report]]> https://www.relmada.com/for-investors/sec-filings/content/0001213900-26-055164/0001213900-26-055164.pdf Tue, 12 May 26 17:01:24 -0400 https://www.relmada.com/for-investors/sec-filings/content/0001213900-26-055164/0001213900-26-055164.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://www.relmada.com/for-investors/sec-filings/content/0001213900-26-055059/0001213900-26-055059.pdf Tue, 12 May 26 16:13:58 -0400 https://www.relmada.com/for-investors/sec-filings/content/0001213900-26-055059/0001213900-26-055059.pdf <![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]> https://www.relmada.com/for-investors/sec-filings/content/0001831942-26-000017/0001831942-26-000017.pdf Mon, 04 May 26 16:25:55 -0400 https://www.relmada.com/for-investors/sec-filings/content/0001831942-26-000017/0001831942-26-000017.pdf <![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]> https://www.relmada.com/for-investors/sec-filings/content/0001213900-26-045194/0001213900-26-045194.pdf Fri, 17 Apr 26 16:33:13 -0400 https://www.relmada.com/for-investors/sec-filings/content/0001213900-26-045194/0001213900-26-045194.pdf <![CDATA[DEF 14A - Definitive proxy statements]]> https://www.relmada.com/for-investors/sec-filings/content/0001213900-26-045192/0001213900-26-045192.pdf Fri, 17 Apr 26 16:31:28 -0400 https://www.relmada.com/for-investors/sec-filings/content/0001213900-26-045192/0001213900-26-045192.pdf <![CDATA[EFFECT - Notice of Effectiveness]]> https://www.relmada.com/for-investors/sec-filings/content/9999999995-26-001136/9999999995-26-001136.pdf Fri, 10 Apr 26 06:03:24 -0400 https://www.relmada.com/for-investors/sec-filings/content/9999999995-26-001136/9999999995-26-001136.pdf <![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]> https://www.relmada.com/for-investors/sec-filings/content/0001213900-26-042007/0001213900-26-042007.pdf Thu, 09 Apr 26 16:23:06 -0400 https://www.relmada.com/for-investors/sec-filings/content/0001213900-26-042007/0001213900-26-042007.pdf